Zai Lab Ltd
NASDAQ:ZLAB

  • LAST PRICE
    27.1000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 27.1000
  • Day Range
    ---
  • 52 Week Range
    22.3500
    49.8100
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ZLAB
Zai Lab Ltd
2.6B
-8.7x
---
IMCR
Immunocore Holdings PLC
2.4B
-34.6x
---
DNLI
Denali Therapeutics Inc
2.5B
-19.0x
---
ARWR
Arrowhead Pharmaceuticals Inc
3.1B
-15.1x
---
ALVO
Alvotech SA
2.5B
-3.5x
---
NTLA
Intellia Therapeutics Inc
2.8B
-5.8x
---
As of 2023-11-30

Company Information

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Contact Information

Headquarters
4560 Jinke Road, Bldg. 1, 4/F, PudongSHANGHAI, SHA, China 201210
Phone
216-163-2588
Fax
216-163-2570

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Du Ying
President, Chief Operating Officer
Joshua Smiley
Chief Financial Officer
Yajing Chen
President - Global Oncology Research and Development
Rafael Amado
President, Head - Global Development of Neuroscience, Autoimmune and Infectious Diseases
Harald Reinhart

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.6B
Revenue (TTM)
$263.5M
Shares Outstanding
98.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.03
EPS
$-3.12
Book Value
$10.89
P/E Ratio
-8.7x
Price/Sales (TTM)
10.0
Price/Cash Flow (TTM)
---
Operating Margin
-128.99%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.